Scalable synthesis of reduced toxicity derivative of amphotericin B
Abstract:
Disclosed is a simplified, readily scalable series of individual methods that collectively constitute a method for the synthesis of C2′epiAmB, an efficacious and reduced-toxicity derivative of amphotericin B (AmB), beginning from AmB. Also provided are various compounds corresponding to intermediates in accordance with the series of methods.
Information query
Patent Agency Ranking
0/0